To Optimize Antenatal Management of Women With Pre Term Labor Using Amniocentesis
NCT04831086 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 247
Last updated 2025-03-12
Summary
Implementation of prediction models of risk of spontaneous delivery within 7 days or of intra-amniotic infection in women with preterm labor and intact membranes
Conditions
- Preterm Birth
- Preterm Labor
- Intra-amniotic Infection
- Amniocentesis Affecting Fetus or Newborn
Interventions
- DRUG
-
Steroid Drug
Steroids doses will be optimized in the intervention group according the risk based on predictive models
- DRUG
-
Tocolytic Agents
Tocolysis duration will be optimized in the intervention group according the risk based on predictive models
Sponsors & Collaborators
-
Hospital Vall d'Hebron
collaborator OTHER -
Hospital Universitario La Fe
collaborator OTHER -
Hospital Universitario La Paz
collaborator OTHER -
Hospital Universitario 12 de Octubre
collaborator OTHER -
Consorci Sanitari de Terrassa
collaborator OTHER -
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
collaborator OTHER -
Hospital Universitario Puerta del Mar
collaborator OTHER -
Hospital Sant Joan de Deu
collaborator OTHER -
Germans Trias i Pujol Hospital
collaborator OTHER -
University Hospital Virgen de las Nieves
collaborator OTHER -
Hospital Clínico Universitario Lozano Blesa
collaborator OTHER -
Parc Taulí Hospital Universitari
collaborator OTHER -
Complexo Hospitalario Universitario de A Coruña
collaborator OTHER -
Hospital Son Llatzer
collaborator OTHER -
Hospital Universitari Joan XXIII de Tarragona.
collaborator OTHER -
Hospital Universitario de Torrejón
collaborator UNKNOWN -
Fundacion Clinic per a la Recerca Biomédica
lead OTHER
Principal Investigators
-
Teresa Cobo, MD, PhD · Fundació Recerca Biomèdica Clínica
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-05-05
- Primary Completion
- 2024-10-30
- Completion
- 2024-12-30
Countries
- Spain
Study Locations
More Related Trials
-
Efficacy of Oral Progesterone and Vaginal Progesterone After Tocolytic Therapy in Threatened Preterm Labor
NCT02989519 ·Status: COMPLETED ·Phase: PHASE3
-
Effectiveness of ACS in Extreme Preemies
NCT02351310 ·Status: WITHDRAWN ·Phase: PHASE3
-
Vaginal PROgesterone as Maintenance Treatment After an epISode of prEterm Labor (PROMISE Study)
NCT00646802 ·Status: COMPLETED ·Phase: PHASE4
-
Utility of Tocolytic Therapy for Maintenance Tocolysis in the Management of Threatened Preterm Delivery
NCT01796522 ·Status: WITHDRAWN ·Phase: PHASE3
-
Prediction of Preterm Delivery with Serial Cervical Length Measurements After Threatened Preterm Labor
NCT05044143 ·Status: RECRUITING
-
The Use of Cervical Length to Reduce Hospital Stay in Women Admitted Because of Preterm Labor.
NCT00432250 ·Status: COMPLETED ·Phase: PHASE4
-
Antibiotic Prophylaxis in Prelabor Rupture of Membranes at Term
NCT01633294 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Evaluate Efficacy Levobupivacaine 0.125% Versuss Ropivacaine 0.2% in Hemodynamic Alterations in Labor and Fetal Repercussions
NCT05877131 ·Status: UNKNOWN ·Phase: PHASE4
-
Vaginal Progesterone to Prevent Preterm Delivery in Women With Preterm Labor
NCT00536003 ·Status: TERMINATED ·Phase: PHASE3
-
Adjunctive Vaginal Progesterone in Management of Preterm Labor
NCT05997563 ·Status: RECRUITING ·Phase: PHASE4
-
A Proof of Concept Study Assessing the Effect of Four Different Single Bolus Intravenous Doses of FE200440 and Placebo on Stopping Preterm Labor
NCT00209326 ·Status: COMPLETED ·Phase: PHASE2
-
Oral Dydrogesterone in the Management of Preterm Labor
NCT03935152 ·Status: COMPLETED ·Phase: PHASE4
-
Amniotomy and Oxytocin for Augmentation of Labour
NCT02318121 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase III Efficacy and Safety Study of Intravenous Retosiban Versus Placebo for Women in Spontaneous Preterm Labor
NCT02377466 ·Status: TERMINATED ·Phase: PHASE3
-
Progestagens for the Tertiary Prophylaxis of Preterm Delivery
NCT01178788 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of the Use of Indomethacin as Co-treatment in Women With Preterm Labor and High Risk of Intraamniotic Inflammation
NCT01577121 ·Status: COMPLETED ·Phase: PHASE2
-
Cervical Pessary to Prevent Preterm Singleton Birth in High Risk Population
NCT04147117 ·Status: UNKNOWN ·Phase: NA
-
Tocolysis in the Management of Preterm Premature Rupture of Membranes Before 34 Weeks of Gestation
NCT03976063 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Prevention of Preterm Labor in Patients With a Previous Episode of Threatened Preterm Labor With Progesterone
NCT01317225 ·Status: UNKNOWN ·Phase: PHASE3
-
Detection of Preterm Labour by Cervical Length
NCT04104984 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Follow up Study to Assess Long Term Safety and Outcomes in Infants and Children Born to Mothers Participating in Retosiban Treatment Studies
NCT02292784 ·Status: COMPLETED ·Phase: PHASE3
-
Management of Threatened Preterm Labor by Cervical Length-based Approach or Conventional Approach
NCT04301388 ·Status: WITHDRAWN ·Phase: NA
-
The Safety, Tolerability And Metabolism Of GSK221149A, In Pregnant Women (30-36 Weeks), In Pre-Term Labor
NCT00404768 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of a New Predictive Test of Preterm Birth in Case of Threatened Preterm Labor
NCT04374916 ·Status: UNKNOWN ·Phase: NA
-
Combined Agent Randomized Trial of Induction of Labor
NCT00504465 ·Status: COMPLETED ·Phase: NA